360 related articles for article (PubMed ID: 18704990)
1. Transcatheter arterial chemoembolization or chemoinfusion for unresectable intrahepatic cholangiocarcinoma: clinical efficacy and factors influencing outcomes.
Kim JH; Yoon HK; Sung KB; Ko GY; Gwon DI; Shin JH; Song HY
Cancer; 2008 Oct; 113(7):1614-22. PubMed ID: 18704990
[TBL] [Abstract][Full Text] [Related]
2. Transcatheter arterial chemoembolization vs. chemoinfusion for unresectable hepatocellular carcinoma in patients with major portal vein thrombosis.
Kim JH; Yoon HK; Kim SY; Kim KM; Ko GY; Gwon DI; Sung KB
Aliment Pharmacol Ther; 2009 Jun; 29(12):1291-8. PubMed ID: 19392861
[TBL] [Abstract][Full Text] [Related]
3. Postoperative adjuvant transcatheter arterial chemoembolisation improves survival of intrahepatic cholangiocarcinoma patients with poor prognostic factors: results of a large monocentric series.
Wu ZF; Zhang HB; Yang N; Zhao WC; Fu Y; Yang GS
Eur J Surg Oncol; 2012 Jul; 38(7):602-10. PubMed ID: 22417704
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.
Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
Hepatogastroenterology; 2002; 49(44):311-6. PubMed ID: 11995440
[TBL] [Abstract][Full Text] [Related]
5. Long-term survival of patients with unresectable hepatocellular carcinoma treated with transcatheter arterial chemoinfusion.
Ha BY; Ahmed A; Sze DY; Razavi MK; Simpson N; Keeffe EB; Nguyen MH
Aliment Pharmacol Ther; 2007 Sep; 26(6):839-46. PubMed ID: 17767468
[TBL] [Abstract][Full Text] [Related]
6. Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients.
Zeng ZC; Tang ZY; Fan J; Zhou J; Qin LX; Ye SL; Sun HC; Wang BL; Li D; Wang JH; Zeng MS; Guo W; Tan YS
Cancer J; 2006; 12(2):113-22. PubMed ID: 16630402
[TBL] [Abstract][Full Text] [Related]
7. Comparative effectiveness of hepatic artery based therapies for unresectable intrahepatic cholangiocarcinoma.
Boehm LM; Jayakrishnan TT; Miura JT; Zacharias AJ; Johnston FM; Turaga KK; Gamblin TC
J Surg Oncol; 2015 Feb; 111(2):213-20. PubMed ID: 25176325
[TBL] [Abstract][Full Text] [Related]
8. Hepatic arterial infusion of mitomycin C with degradable starch microspheres for unresectable intrahepatic cholangiocarcinoma.
Shitara K; Ikami I; Munakata M; Muto O; Sakata Y
Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):241-6. PubMed ID: 18222071
[TBL] [Abstract][Full Text] [Related]
9. Locally advanced intrahepatic cholangiocarcinoma successfully resected after transcatheter arterial chemoembolization with degradable starch microspheres: report of a case.
Wu Y; Saiura A; Yamamoto J; Koga R; Asahara S; Kamei A; Takano K; Ikari T; Seki M; Yamaguchi T; Muto T
Hepatogastroenterology; 2007; 54(77):1345-7. PubMed ID: 17708251
[TBL] [Abstract][Full Text] [Related]
10. Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single-institution experience.
Gusani NJ; Balaa FK; Steel JL; Geller DA; Marsh JW; Zajko AB; Carr BI; Gamblin TC
J Gastrointest Surg; 2008 Jan; 12(1):129-37. PubMed ID: 17851723
[TBL] [Abstract][Full Text] [Related]
11. Transarterial chemoembolization versus supportive therapy in the palliative treatment of unresectable intrahepatic cholangiocarcinoma.
Park SY; Kim JH; Yoon HJ; Lee IS; Yoon HK; Kim KP
Clin Radiol; 2011 Apr; 66(4):322-8. PubMed ID: 21356394
[TBL] [Abstract][Full Text] [Related]
12. Chemoembolization for hepatocellular carcinoma: multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohort.
Hu HT; Kim JH; Lee LS; Kim KA; Ko GY; Yoon HK; Sung KB; Gwon DI; Shin JH; Song HY
J Vasc Interv Radiol; 2011 Jul; 22(7):917-23. PubMed ID: 21571545
[TBL] [Abstract][Full Text] [Related]
13. Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness.
Sergio A; Cristofori C; Cardin R; Pivetta G; Ragazzi R; Baldan A; Girardi L; Cillo U; Burra P; Giacomin A; Farinati F
Am J Gastroenterol; 2008 Apr; 103(4):914-21. PubMed ID: 18177453
[TBL] [Abstract][Full Text] [Related]
14. Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy.
Kahaleh M; Mishra R; Shami VM; Northup PG; Berg CL; Bashlor P; Jones P; Ellen K; Weiss GR; Brenin CM; Kurth BE; Rich TA; Adams RB; Yeaton P
Clin Gastroenterol Hepatol; 2008 Mar; 6(3):290-7. PubMed ID: 18255347
[TBL] [Abstract][Full Text] [Related]
15. Locoregional intra-arterial therapies for unresectable intrahepatic cholangiocarcinoma.
Hong K; Geschwind JF
Semin Oncol; 2010 Apr; 37(2):110-7. PubMed ID: 20494703
[TBL] [Abstract][Full Text] [Related]
16. Preoperative transcatheter selective arterial chemoembolization in treatment of unresectable hepatoblastoma in infants and children.
Li JP; Chu JP; Yang JY; Chen W; Wang Y; Huang YH
Cardiovasc Intervent Radiol; 2008; 31(6):1117-23. PubMed ID: 18560935
[TBL] [Abstract][Full Text] [Related]
17. Nonresectable combined hepatocellular carcinoma and cholangiocarcinoma: analysis of the response and prognostic factors after transcatheter arterial chemoembolization.
Kim JH; Yoon HK; Ko GY; Gwon DI; Jang CS; Song HY; Shin JH; Sung KB
Radiology; 2010 Apr; 255(1):270-7. PubMed ID: 20308463
[TBL] [Abstract][Full Text] [Related]
18. Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution.
Burger I; Hong K; Schulick R; Georgiades C; Thuluvath P; Choti M; Kamel I; Geschwind JF
J Vasc Interv Radiol; 2005 Mar; 16(3):353-61. PubMed ID: 15758131
[TBL] [Abstract][Full Text] [Related]
19. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
Ito F; Agni R; Rettammel RJ; Been MJ; Cho CS; Mahvi DM; Rikkers LF; Weber SM
Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638
[TBL] [Abstract][Full Text] [Related]
20. The clinical presentation and prognostic factors for intrahepatic and extrahepatic cholangiocarcinoma in a tertiary care centre.
Singal AG; Rakoski MO; Salgia R; Pelletier S; Welling TH; Fontana RJ; Lok AS; Marrero JA
Aliment Pharmacol Ther; 2010 Mar; 31(6):625-33. PubMed ID: 20003093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
